Efficacy-oriented compatibility for component-based Chinese medicine

Single-target drugs have not achieved satisfactory therapeutic effects for complex diseases involving multiple factors. Instead, innovations in recent drug research and development have revealed the emergence of compound drugs, such as cocktail therapies and “polypills”, as the frontier in new drug development. A traditional Chinese medicine (TCM) prescription that is usually composed of several medicinal herbs can serve a typical representative of compound medicines. Although the traditional compatibility theory of TCM cannot be well expressed using modern scientific language nowadays, the fundamental purpose of TCM compatibility can be understood as promoting efficacy and reducing toxicity. This paper introduces the theory and methods of efficacy-oriented compatibility for developing component-based Chinese medicines.

[1]  Péter Csermely,et al.  The efficiency of multi-target drugs: the network approach might help drug design. , 2004, Trends in pharmacological sciences.

[2]  Curtis J Henrich,et al.  Matching the power of high throughput screening to the chemical diversity of natural products. , 2013, Natural product reports.

[3]  Yongliang Yang,et al.  Target discovery from data mining approaches. , 2009, Drug discovery today.

[4]  Lingyan Yu,et al.  QI-SHEN-YI-QI accelerates angiogenesis after myocardial infarction in rats. , 2010, International journal of cardiology.

[5]  N J Wald,et al.  A strategy to reduce cardiovascular disease by more than 80% , 2003, BMJ : British Medical Journal.

[6]  W. J. Elliott,et al.  Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial , 2010 .

[7]  J. Medina-Franco,et al.  Shifting from the single to the multitarget paradigm in drug discovery. , 2013, Drug discovery today.

[8]  T. Gilliam,et al.  Molecular triangulation: bridging linkage and molecular-network information for identifying candidate genes in Alzheimer's disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[9]  M. Sakharkar,et al.  Targetability of human disease genes. , 2007, Current drug discovery technologies.

[10]  Lakshmanan K. Iyer,et al.  A combined approach to data mining of textual and structured data to identify cancer-related targets , 2006, BMC Bioinformatics.

[11]  Baoyan Liu,et al.  Qi-Shen-Yi-Qi Dripping Pills for the Secondary Prevention of Myocardial Infarction: A Randomised Clinical Trial , 2013, Evidence-based complementary and alternative medicine : eCAM.

[12]  Meng Zhang,et al.  High-throughput screening for bioactive components from traditional Chinese medicine. , 2010, Combinatorial chemistry & high throughput screening.

[13]  David S. Wishart,et al.  Nucleic Acids Research Polysearch: a Web-based Text Mining System for Extracting Relationships between Human Diseases, Genes, Mutations, Drugs Polysearch: a Web-based Text Mining System for Extracting Relationships between Human Diseases, Genes, Mutations, Drugs and Metabolites , 2008 .

[14]  Jane A. Craycroft,et al.  Developing a library of authenticated Traditional Chinese Medicinal (TCM) plants for systematic biological evaluation--rationale, methods and preliminary results from a Sino-American collaboration. , 2011, Fitoterapia.

[15]  Yun-Fei Li,et al.  A method for the production and characterization of fractionated libraries from Chinese herbal formulas. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[16]  F. Sams-Dodd.  Target-based drug discovery: is something wrong? , 2005, Drug discovery today.

[17]  S. Yusuf,et al.  Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial , 2009, The Lancet.

[18]  Lorenz M Mayr,et al.  The Future of High-Throughput Screening , 2008, Journal of biomolecular screening.

[19]  Yi Wang,et al.  Identifying roles of “Jun-Chen-Zuo-Shi” component herbs of QiShenYiQi formula in treating acute myocardial ischemia by network pharmacology , 2014, Chinese Medicine.

[20]  Wei Liu,et al.  A Network Pharmacology Study of Chinese Medicine QiShenYiQi to Reveal Its Underlying Multi-Compound, Multi-Target, Multi-Pathway Mode of Action , 2014, PloS one.

[21]  Dragomir R. Radev,et al.  Identifying gene-disease associations using centrality on a literature mined gene-interaction network , 2008, ISMB.

[22]  A. Hopkins.  Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.

[23]  Sridhar Ramaswamy,et al.  Rational design of cancer-drug combinations. , 2007, The New England journal of medicine.

[24]  Albert-László Barabási,et al.  Error and attack tolerance of complex networks , 2000, Nature.

[25]  L. Mayer,et al.  Optimizing combination chemotherapy by controlling drug ratios. , 2007, Molecular interventions.

[26]  A. Barabasi,et al.  Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.

[27]  Phil Szuromi,et al.  Rethinking Drug Discovery , 2004, Science.